Therapeutic expertise isn’t just important. It’s mission-critical. Because to get to the right solutions for patients, you need to know what the problems are, and what questions to ask.
And it never will. How you find, and treat, patients in oncology must be different than in infectious disease. Understanding regulatory and approval pathways is an entirely different journey in pediatrics than it is for Alzheimer’s treatments.
We’ve known this, but until today our ability to access, connect and leverage data, technology, and advanced analytics, and apply the critical lens of domain expertise has limited how precise we can be.
Explore IQVIA's deep domain expertise in the therapeutic and specialty areas you are committed to.
Through our Therapeutic Centers of Excellence, IQVIA connects your clinical program with strong scientific and medical expertise, deep therapeutic insights and unrivaled clinical trials experience. To help you find the most direct route from breakthrough science to new therapies for patients.
From the earliest planning stages of clinical development through launch and real world assessment, therapeutic expertise is key to ensuring we are asking the right questions.
Building a predictive algorithm that can find Alzheimer's patients earlier, before they are even patients, doesn't just take data science. It requires deep domain expertise in the epidemiology, progression and experience of the disease to know what is clinically relevant. It takes unparalleled non-identified data, from a range of sources beyond EMRs. It takes analytics that can create the right composites and a well-taught machine learning system that will only get better. This is more than data science. This is human data science.
As the leader in human data science, IQVIA is at the forefront of integrating human science expertise with advances in analytics and technology to help customers ask better questions, and extract more meaningful insights.
Because to move healthcare forward, we must be able to respond to and reflect on the challenges, questions and concerns that are as diverse and as complex as the diseases themselves.
Assess your protocol against real world evidence using advanced analytics, and reduce the risk of costly amendments.
Tap into evidence networks in oncology, neurology, immunology, and other therapy areas to enrich your studies.